Semaglutide Dosage Guide
95/100 confidenceComplete guide to Semaglutide dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
250 mcg
Route
subq
Frequency
Weekly
Cycle Length
4 weeks
Detailed Dosage Information
Wegovy (weight loss): Start at 0.25mg weekly, titrate up to 2.4mg weekly over 16-20 weeks. Ozempic (diabetes): 0.25mg to 1mg weekly. Research protocols vary.
Administration Method
Subcutaneous injection once weekly, typically in abdomen, thigh, or upper arm. Rybelsus is taken orally on empty stomach. Dose titration is essential to minimize GI side effects.
Research Backing
Full FDA prescribing information \+ STEP trials and SELECT cardiovascular outcome study (large Phase 3 cohorts).
Side Effects to Monitor
Common: nausea, vomiting, diarrhea, constipation, abdominal pain. These typically decrease over time. May cause injection site reactions.
Safety Considerations & Risks
Contraindicated with personal/family history of medullary thyroid carcinoma or MEN2 syndrome. Risk of pancreatitis, gallbladder disease, and potential retinopathy progression in diabetics.